We are live on ! Find out more
RNAZ icon

TransCode Therapeutics
RNAZ

16 hedge funds and large institutions have $1.06M invested in TransCode Therapeutics in 2025 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 3 increasing their positions, reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

3,074% more capital invested

Capital invested by funds: $33.4K → $1.06M (+$1.03M)

433% more funds holding

Funds holding: 3 → 16 (+13)

0.28% more ownership

Funds ownership: 0.05% → 0.33% (+0.28%)

Holders
16
Holders Change
+13
Holders Change %
+433.33%
% of All Funds
0.21%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
13
Increased
3
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
AFM
Anson Funds Management
Texas
+$6.69M
2
UBS Group
UBS Group
Switzerland
+$1.17M
3
SM
Sabby Management
Florida
+$1.05M
4
WAM
Warberg Asset Management
Illinois
+$229K
5
CCM
Corsair Capital Management
New York
+$183K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
AFM
1
Anson Funds Management
Texas
$724K +$6.69M +52,218 New
UBS Group
2
UBS Group
Switzerland
$131K +$1.17M +9,116 +2,941%
SM
3
Sabby Management
Florida
$113K +$1.05M +8,180 New
WAM
4
Warberg Asset Management
Illinois
$24.8K +$229K +1,786 New
CCM
5
Corsair Capital Management
New York
$19.8K +$183K +1,429 New
Commonwealth Equity Services
6
Commonwealth Equity Services
Massachusetts
$11K +$99.2K +774 New
Acadian Asset Management
7
Acadian Asset Management
Massachusetts
$11K +$102K +797 New
SC
8
SouthState Corp
Florida
$8.91K +$82.4K +643 New
GSC
9
Ground Swell Capital
South Carolina
$7.11K +$65.7K +513 New
MG
10
Marex Group
$6.28K +$58K +453 New
Morgan Stanley
11
Morgan Stanley
New York
$2.48K +$21.5K +168 +1,527%
TRCT
12
Tower Research Capital (TRC)
New York
$756 +$2.82K +22 +67%
SS
13
SBI Securities
Japan
$185 +$1.67K +13 New
Osaic Holdings
14
Osaic Holdings
Arizona
$50 +$513 +4 New
Fidelity Investments
15
Fidelity Investments
Massachusetts
$12 +$128 +1 New
Bank of America
16
Bank of America
North Carolina
$3 – – –
Royal Bank of Canada
17
Royal Bank of Canada
Ontario, Canada
– +$1.15K +9 New

RNAZ Hedge Fund Activity: Q1 2025 in Review

16 of the 7,459 institutional investors tracked by Wall St. Rank reported a position in TransCode Therapeutics (RNAZ) for Q1 2025, worth a combined $1.06M — up 3,074% from $33.4K a quarter earlier.

Buyers outnumbered sellers: 13 funds opened new RNAZ positions and 0 closed out — a net gain of 13 holders — while 3 added to existing stakes and 0 trimmed.

The largest buyer was Anson Funds Management, opening a new position worth an estimated $6.69M.

  • 16 institutional investors held TransCode Therapeutics (RNAZ) as of Q1 2025, up from 3 in Q4 2024.
  • Funds reported $1.06M of TransCode Therapeutics stock for Q1 2025, up 3,074% quarter-over-quarter.
  • 13 funds opened new TransCode Therapeutics positions in Q1 2025 and 0 closed out, a net change of +13 holders.
  • The largest TransCode Therapeutics buyer in Q1 2025 was Anson Funds Management, an estimated $6.69M added.

Based on aggregated 13F filings for Q1 2025.